Prefrontal cortex molecular clock modulates development of depression-like phenotype and rapid antidepressant response in mice

David H Sarrazin,Wilf Gardner,Carole Marchese,Martin Balzinger,Chockalingam Ramanathan,Marion Schott,Stanislav Rozov,Maxime Veleanu,Stefan Vestring,Claus Normann,Tomi Rantamäki,Benedicte Antoine,Michel Barrot,Etienne Challet,Patrice Bourgin,Tsvetan Serchov

DOI: https://doi.org/10.1038/s41467-024-51716-9

2024-08-23

Abstract:Depression is associated with dysregulated circadian rhythms, but the role of intrinsic clocks in mood-controlling brain regions remains poorly understood. We found increased circadian negative loop and decreased positive clock regulators expression in the medial prefrontal cortex (mPFC) of a mouse model of depression, and a subsequent clock countermodulation by the rapid antidepressant ketamine. Selective Bmal1KO in CaMK2a excitatory neurons revealed that the functional mPFC clock is an essential factor for the development of a depression-like phenotype and ketamine effects. Per2 silencing in mPFC produced antidepressant-like effects, while REV-ERB agonism enhanced the depression-like phenotype and suppressed ketamine action. Pharmacological potentiation of clock positive modulator ROR elicited antidepressant-like effects, upregulating plasticity protein Homer1a, synaptic AMPA receptors expression and plasticity-related slow wave activity specifically in the mPFC. Our data demonstrate a critical role for mPFC molecular clock in regulating depression-like behavior and the therapeutic potential of clock pharmacological manipulations influencing glutamatergic-dependent plasticity.